PTHLH and breast carcinoma: In a clinical study of breast cancer metastases to the bone, 92% of bone metastases scored high by immunohistochemistry for parathyroid-hormone-related protein (PTHrP) compared to 17% in nonbone sites [63], an observation that was further supported by similar in situ hybridization results [64].